Concurrent loss of INI1, PBRM1, and BRM expression in epithelioid sarcoma: Implications for the cocontributions of multiple SWI/SNF complex members to pathogenesis

Human Pathology

Volumn 45, Issue 11, 2014, Pages 2247-2254

  Li, Li ^a,b   Fan, Xiang Shan ^a   Xia, Qiu Yuan ^a   Rao, Qiu ^a   Liu, Biao ^a   Yu, Bo ^a   Shi, Qun Li ^a   Lu, Zhen Feng ^a   Zhou, Xiao Jun ^a  

^a NANJING UNIVERSITY   (China)

^b ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

ATPase complex; BRM; Epithelioid sarcoma; INI1; PBRM1; SWI SNF

Indexed keywords

BIOLOGICAL MARKER; BRM PROTEIN; CD34 ANTIGEN; CYTOKERATIN AE1; CYTOKERATIN AE3; EPITHELIAL MEMBRANE ANTIGEN; INI1 PROTEIN; PBRM1 PROTEIN; PROTEIN; UNCLASSIFIED DRUG; VIMENTIN; DNA BINDING PROTEIN; NONHISTONE PROTEIN; NUCLEAR PROTEIN; PBRM1 PROTEIN, HUMAN; SMARCA2 PROTEIN, HUMAN; SMARCB1 PROTEIN, HUMAN; TRANSCRIPTION FACTOR; TUMOR MARKER;

ADOLESCENT; ADULT; AGED; ARTICLE; CHROMATIN ASSEMBLY AND DISASSEMBLY; CLINICAL ARTICLE; CLINICAL FEATURE; EPITHELIOID SARCOMA; FEMALE; GENE ACTIVITY; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MATING TYPE; PATHOGENESIS; PROTEIN EXPRESSION; SUCROSE NONFERMENTATION COMPLEX; METABOLISM; MIDDLE AGED; PATHOLOGY; RHABDOID TUMOR; SARCOMA; SOFT TISSUE TUMOR; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CHROMOSOMAL PROTEINS, NON-HISTONE; DNA-BINDING PROTEINS; FEMALE; HUMANS; MALE; MIDDLE AGED; NUCLEAR PROTEINS; RHABDOID TUMOR; SARCOMA; SOFT TISSUE NEOPLASMS; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84908333352     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2014.06.027     Document Type: Article

References (22)

1. B.G. Wilson, and C.W. Roberts SWI/SNF nucleosome remodellers and cancer Nat Rev Cancer 11 2011 481 492
2. F.M. Enzinger Epitheloid sarcoma. A sarcoma simulating a granuloma or a carcinoma Cancer 26 1970 1029 1041
3. L. Guillou, C. Wadden, and J.M. Coindre "Proximal-type" epithelioid sarcoma, a distinctive aggressive neoplasm showing rhabdoid features. Clinicopathologic, immunohistochemical, and ultrastructural study of a series Am J Surg Pathol 21 1997 130 146
4. E. Lualdi, P. Modena, and M. Debiec-Rychter Molecular cytogenetic characterization of proximal-type epithelioid sarcoma Genes Chromosomes Cancer 41 2004 283 290
5. J.L. Hornick, P. Dal Cin, and C.D. Fletcher Loss of INI1 expression is characteristic of both conventional and proximal-type epithelioid sarcoma Am J Surg Pathol 33 2009 542 550
6. R. Schneppenheim, M.C. Fruhwald, and S. Gesk Germline nonsense mutation and somatic inactivation of SMARCA4/BRG1 in a family with rhabdoid tumor predisposition syndrome Am J Hum Genet 86 2010 279 284
7. C.J. Guidi, A.T. Sands, and B.P. Zambrowicz Disruption of Ini1 leads to peri-implantation lethality and tumorigenesis in mice Mol Cell Biol 21 2001 3598 3603
8. S. Bultman, T. Gebuhr, and D. Yee A Brg1 null mutation in the mouse reveals functional differences among mammalian SWI/SNF complexes Mol Cell 6 2000 1287 1295
9. J.K. Kim, S.O. Huh, and H. Choi Srg3, a mouse homolog of yeast SWI3, is essential for early embryogenesis and involved in brain development Mol Cell Biol 21 2001 7787 7795
10. P.P. Medina, O.A. Romero, and T. Kohno Frequent BRG1/SMARCA4-inactivating mutations in human lung cancer cell lines Hum Mutat 29 2008 617 622
11. T.J. Pugh, S.D. Weeraratne, and T.C. Archer Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations Nature 488 2012 106 110
12. A.H. Shain, C.P. Giacomini, and K. Matsukuma Convergent structural alterations define SWItch/Sucrose NonFermentable (SWI/SNF) chromatin remodeler as a central tumor suppressive complex in pancreatic cancer Proc Natl Acad Sci U S A 109 2012 E252 E259
13. H. Shen, N. Powers, and N. Saini The SWI/SNF ATPase Brm is a gatekeeper of proliferative control in prostate cancer Cancer Res 68 2008 10154 10162
14. S. Glaros, G.M. Cirrincione, and C. Muchardt The reversible epigenetic silencing of BRM: implications for clinical targeted therapy Oncogene 26 2007 7058 7066
15. I. Varela, P. Tarpey, and K. Raine Exome sequencing identifies frequent mutation of the SWI/SNF complex gene hPB1 in renal carcinoma Nature 469 2011 539 542
16. C.D.M. Fletcher, J.A. Bridge, and P.C.W. Hogendoorn WHO Classification of Tumours of Soft Tissue and Bone 2013 IARC Press Lyon, France 216 218
17. H.M. Ross, J.J. Lewis, and J.M. Woodruff Epithelioid sarcoma: clinical behavior and prognostic factors of survival Ann Surg Oncol 4 1997 491 495
18. M. Brenca, S. Rossi, and E. Lorenzetto SMARCB1/INI1 genetic inactivation is responsible for tumorigenic properties of epithelioid sarcoma cell line VAESBJ Mol Cancer Ther 12 2013 1060 1072
19. W. Xia, S. Nagase, and A.G. Montia BAF180 is a critical regulator of p21 induction and a tumor suppressor mutated in breast cancer Cancer Res 68 2008 1667 1674
20. A.E. Burrows, A. Smogorzewska, and S.J. Elledge Polybromo-associated BRG1-associated factor components BRD7 and BAF180 are critical regulators of p53 required for induction of replicative senescence Proc Natl Acad Sci U S A 107 2010 14280 14285
21. Y. Jiao, T.M. Pawlik, and R.A. Anders Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and hPB1 in intrahepatic cholangiocarcinomas Nat Genet 45 2013 1470 1473
22. S. Gramling, C. Rogers, and G. Liu Pharmacologic reversal of epigenetic silencing of the anticancer protein BRM: a novel targeted treatment strategy Oncogene 30 2011 3289 3294